Head and Neck Squamous Cell Carcinoma — Trials

Head and Neck Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,589 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 592
Recruiting: 313
Ph III recruiting: 31
Growth YoY: +30.1%
Industry share: 28%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (247)

clinicaltrialsPublishedShowing 201–210 of 210 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00459043	Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck	completed	Phase 2	30	Dana-Farber Cancer InstituteOTHER	1	Jul 3, 2013	clinicaltrials
NCT00410826	Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer	completed	Phase 2	204	University of WashingtonOTHER	1	May 10, 2013